Reneuron Group Plc (RENE.LN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [LSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [LSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 03/31
| 03-2018 | 03-2017 | 03-2016 | 03-2015 | 03-2014 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 27,911 | 28,125 | 17,426 | 12,382 | 14,917 |
| Marketable Securities | 9,500 | 24,936 | 43,283 | N/A | 6,000 |
| Other current assets | 4,295 | 5,075 | 4,185 | 1,672 | 1,430 |
| TOTAL | $41,706 | $58,136 | $64,894 | $14,054 | $22,347 |
| Non-Current Assets | |||||
| PPE Net | 726 | 724 | 361 | 161 | 225 |
| Intangibles | 186 | 0 | 1,591 | 1,591 | 1,272 |
| Other Non-Current Assets | 0 | 0 | 5,011 | 281 | 275 |
| TOTAL | $912 | $724 | $6,963 | $2,033 | $1,772 |
| Total Assets | $42,618 | $58,860 | $71,857 | $16,087 | $24,119 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 1,924 | 1,817 | 1,502 | 1,059 | 1,159 |
| TOTAL | $5,949 | $5,703 | $4,199 | $2,345 | $2,036 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 0 | 0 | 0 | 605 | 364 |
| TOTAL | $0 | $0 | $0 | $606 | $366 |
| Total Liabilities | $5,949 | $5,703 | $4,199 | $2,951 | $2,402 |
| Shareholders' Equity | |||||
| Common Shares | 316 | 31,646 | 31,646 | 17,888 | 17,888 |
| Retained earnings | -103,868 | -87,380 | -72,879 | -62,206 | -53,625 |
| Other shareholders' equity | 2,223 | 2,223 | 2,223 | 2,223 | 2,223 |
| TOTAL | $36,669 | $53,157 | $67,658 | $13,136 | $21,717 |
| Total Liabilities And Equity | $42,618 | $58,860 | $71,857 | $16,087 | $24,119 |